| Literature DB >> 31094320 |
Graham R Thew1,2,3, Candice Lym Powell4, Amy Pl Kwok5, Mandy H Lissillour Chan6, Jennifer Wild1, Emma Warnock-Parkes1,7, Patrick Wl Leung8, David M Clark1.
Abstract
BACKGROUND: Guided internet-based psychological interventions show substantial promise for expanding access to evidence-based mental health care. However, this can only be achieved if results of tightly controlled studies from the treatment developers can also be achieved in other independent settings. This dissemination depends critically on developing efficient and effective ways to train professionals to deliver these interventions. Unfortunately, descriptions of therapist training and its evaluation are often limited or absent within dissemination studies.Entities:
Keywords: Hong Kong; anxiety; benchmarking; clinical competence; cognitive therapy; cross-cultural comparison; internet; mental health; psychology, clinical; social phobia
Year: 2019 PMID: 31094320 PMCID: PMC6540721 DOI: 10.2196/13446
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Figure 1Therapists’ self-reported knowledge (top panel) and skills (bottom panel) ratings for internet-based Cognitive Therapy for social anxiety disorder following each phase of training.
Therapists’ scores on each component of the skills test.
| Skill assessed | Maximum score | Therapist 1 | Therapist 2 | Therapist 3 |
| Interpreting client questionnaire responses and treatment planning | 16 | 12 | 13 | 11 |
| Reviewing patients’ individualized cognitive models | 9 | 6 | 4 | 4 |
| Conducting the | 3 | 3 | 2 | 3 |
| Planning phone calls | 5 | 3 | 4 | 4 |
| Reviewing patients’ behavioral experiments | 6 | 5 | 5 | 6 |
| Reviewing patients’ writing in modules | 5 | 3 | 1 | 2 |
| Responding to a patient message | 7 | 4 | 2 | 3 |
| Reviewing patients’ therapy blueprints | 4 | 3 | 2 | 2 |
| Total | 55 | 39 (71%) | 33 (60%) | 35 (64%) |
Means and SDs at pretreatment, posttreatment, and 3-month follow-up (N=6).
| Measure | Pretreatment, mean (SD) | Posttreatment, mean (SD) | 3-Month follow-up, mean (SD) |
| LSASa | 75.8 (30.4) | 22.0 (21.0) | 17.8 (17.2) |
| SPWSSb | 31.7 (11.0) | 14.0 (8.1) | 14.0 (8.9) |
| SPINc | 43.3 (16.5) | 20.0 (12.2) | 18.7 (16.9) |
| FNEd | 25.2 (3.0) | 19.3 (8.5) | 18.7 (9.8) |
| SPSe | 32.7 (20.4) | 12.7 (7.4) | 9.7 (9.4) |
| SIASf | 53.3 (16.2) | 28.7 (10.1) | 27.3 (12.2) |
| SCQ-fg | 3.1 (1.1) | 1.5 (0.6) | 1.5 (0.8) |
| SCQ-bh | 47.7 (20.5) | 15.6 (13.5) | 14.5 (20.3) |
| SBQi | 43.0 (13.2) | 22.7 (9.5) | 27.7 (17.0) |
| SAQj | 214.5 (44.1) | 146.3 (39.2) | 159.7 (73.8) |
| Social participation | 37.2 (5.8) | 53.5 (14.9) | 60.3 (18.5) |
| Social satisfaction | 17.5 (5.8) | 22.8 (3.2) | 22.5 (8.4) |
| PHQk | 11.3 (7.1) | 5.2 (2.6) | 6.2 (5.7) |
| GADl | 13.2 (4.5) | 6.3 (3.3) | 6.8 (5.9) |
| WSASm | 19.5 (7.8) | 8.5 (4.2) | 9.2 (9.2) |
aLSAS: Liebowitz Social Anxiety Scale.
bSPWSS: Social Phobia Weekly Summary Scale.
cSPIN: Social Phobia Inventory.
dFNE: Fear of Negative Evaluation Scale.
eSPS: Social Phobia Scale.
fSIAS: Social Interaction Anxiety Scale.
gSCQ-f: Social Cognitions Questionnaire (frequency; mean score).
hSCQ-b: Social Cognitions Questionnaire (belief; mean score).
iSBQ: Social Behavior Questionnaire.
jSAQ: Social Attitudes Questionnaire.
kPHQ: Patient Health Questionnaire.
lGAD: Generalized Anxiety Disorder Questionnaire.
mWSAS: Work and Social Adjustment Scale.
Within-group effect sizes between pretreatment, posttreatment, and 3-month follow-up (N=6).
| Measure | Cohen | ||
| Pre-to-Post | Pre-to-Follow-up | Post-to-Follow-up | |
| LSASa | 2.06 (0.66 to 3.46) | 2.34 (0.88 to 3.81) | 0.22 (−0.92 to 1.35) |
| SPWSSb | 1.83 (0.48 to 3.18) | 1.76 (0.43 to 3.10) | 0.00 (−1.13 to 1.13) |
| SPINc | 1.61 (0.31 to 2.91) | 1.48 (0.20 to 2.75) | 0.09 (−1.04 to 1.22) |
| FNEd | 0.92 (−0.27 to 2.10) | 0.90 (−0.29 to 2.09) | 0.07 (−1.06 to 1.20) |
| SPSe | 1.30 (0.06 to 2.55) | 1.45 (0.18 to 2.72) | 0.35 (−0.79 to 1.49) |
| SIASf | 1.82 (0.48 to 3.17) | 1.81 (0.46 to 3.15) | 0.12 (−1.01 to 1.25) |
| SCQ-fg | 1.89 (0.53 to 3.25) | 1.71 (0.39 to 3.03) | −0.02 (−1.15 to 1.11) |
| SCQ-bh | 1.85 (0.50 to 3.20) | 1.63 (0.32 to 2.93) | 0.06 (−1.07 to 1.19) |
| SBQi | 1.76 (0.43 to 3.10) | 1.01 (−0.19 to 2.21) | −0.36 (−1.50 to 0.78) |
| SAQj | 1.63 (0.33 to 2.94) | 0.90 (−0.29 to 2.09) | −0.23 (−1.36 to 0.91) |
| Social participation | 1.45 (0.17 to 2.72) | 1.69 (0.37 to 3.01) | 0.41 (−0.74 to 1.55) |
| Social satisfaction | 1.14 (−0.08 to 2.36) | 0.69 (−0.47 to 1.86) | −0.05 (−1.18 to 1.08) |
| PHQk | 1.15 (−0.07 to 2.37) | 0.80 (−0.38 to 1.98) | −0.22 (−1.36 to 0.91) |
| GADl | 1.72 (0.39 to 3.04) | 1.20 (−0.03 to 2.43) | −0.10 (−1.24 to 1.03) |
| WSASm | 1.75 (0.42 to 3.08) | 1.21 (−0.02 to 2.44) | −0.09 (−1.23 to 1.04) |
aLSAS: Liebowitz Social Anxiety Scale.
bSPWSS: Social Phobia Weekly Summary Scale.
cSPIN: Social Phobia Inventory.
dFNE: Fear of Negative Evaluation Scale.
eSPS: Social Phobia Scale.
fSIAS: Social Interaction Anxiety Scale.
gSCQ-f: Social Cognitions Questionnaire (frequency; mean score).
hSCQ-b: Social Cognitions Questionnaire (belief; mean score).
iSBQ: Social Behavior Questionnaire.
jSAQ: Social Attitudes Questionnaire.
kPHQ: Patient Health Questionnaire.
lGAD: Generalized Anxiety Disorder Questionnaire.
mWSAS: Work and Social Adjustment Scale.
Figure 2Weekly scores on the Liebowitz Social Anxiety Scale (self-report) across treatment for the 6 pilot patients. Week 15 represents the posttreatment assessment. The dotted line represents the clinical cutoff score of 38 points.